Tandem Diabetes Care (TNDM) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$98.4 million.
- Tandem Diabetes Care's Other Gross PP&E Adjustments fell 1255.36% to -$98.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.4 million, marking a year-over-year decrease of 1255.36%. This contributed to the annual value of $55.7 million for FY2024, which is 3400.41% up from last year.
- According to the latest figures from Q3 2025, Tandem Diabetes Care's Other Gross PP&E Adjustments is -$98.4 million, which was down 1255.36% from -$98.4 million recorded in Q2 2025.
- Tandem Diabetes Care's 5-year Other Gross PP&E Adjustments high stood at $72.1 million for Q4 2021, and its period low was -$126.7 million during Q2 2022.
- In the last 5 years, Tandem Diabetes Care's Other Gross PP&E Adjustments had a median value of -$88.3 million in 2024 and averaged -$57.4 million.
- In the last 5 years, Tandem Diabetes Care's Other Gross PP&E Adjustments crashed by 124922.73% in 2021 and then soared by 19462.45% in 2023.
- Over the past 5 years, Tandem Diabetes Care's Other Gross PP&E Adjustments (Quarter) stood at $72.1 million in 2021, then crashed by 80.43% to $14.1 million in 2022, then skyrocketed by 194.62% to $41.5 million in 2023, then soared by 34.0% to $55.7 million in 2024, then crashed by 276.68% to -$98.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$98.4 million for Q3 2025, versus -$98.4 million for Q2 2025 and -$101.0 million for Q1 2025.